0.5 ML sumatriptan 12 MG/ML Prefilled Syringe — RxCUI 727339
RxNorm drug concept · Semantic clinical drug
RxCUI 727339
Semantic clinical drug · SCD
● Current RxNorm concept 3 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI727339
Official name0.5 ML sumatriptan 12 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assumatriptan 6 MG per 0.5 ML Prefilled Syringe; SUMAtriptan 6 MG in 0.5 ML Prefilled Syringe; sumatriptan (as sumatriptan succinate) 6 MG per 0.5 ML Prefilled Syringe
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sumatriptan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Sumatriptan is specifically for migraine headaches — it's not a general pain reliever like ibuprofen. It's designed to stop a migraine attack once it's already started, with or wit...
- What exactly is sumatriptan for? Will it work on any headache?
- You don't need to wait until it's unbearable. Taking sumatriptan at the first sign of a migraine is generally the right move — don't wait it out. That said, it is meant for confirm...
- When should I take sumatriptan — do I have to wait until the headache is severe?
🕸️ Concept Web — How 0.5 ML sumatriptan 12 MG/ML Prefilled Syringe Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
0.5 ML sumatriptan 12 MG/ML Prefilled Syringe
RxCUI 727339 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Sumatriptan
37418IN
-
Sumatriptan
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sumatriptan Prefilled Syringe
727338SCDF -
Sumatriptan Injectable Product
1163610SCDG -
Prefilled Syringe
721656DF -
Injectable Product
1151126DFG
-
Sumatriptan Prefilled Syringe
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sumatriptan 12 MG/ML
330516SCDC
-
Sumatriptan 12 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sumatriptan 12 MG/ML
SCDC · 330516 -
Sumatriptan Prefilled Syringe
SCDF · 727338 -
Sumatriptan Injectable Product
SCDG · 1163610
📦 FDA Products & Package NDCs
3 products · 3 package NDCs
3 package NDCs map to RxCUI 727339 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 83270-0005-01 | 1 BLISTER PACK in 1 CARTON (83270-005-01) / 1 SYRINGE in 1... | sumatriptan | ONESOURCE SPECIALTY PHARMA LIMITED | 2025-06-30 |
| 83270-0151-07 | 2 SYRINGE in 1 CARTON (83270-151-07) / .5 mL in 1 SYRINGE | sumatriptan | ONESOURCE SPECIALTY PHARMA LIMITED | 2026-02-02 |
| 83270-0152-07 | 2 SYRINGE in 1 CARTON (83270-152-07) / .5 mL in 1 SYRINGE | sumatriptan | ONESOURCE SPECIALTY PHARMA LIMITED | 2026-02-02 |
Observed labelers:
ONESOURCE SPECIALTY PHARMA LIMITED (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.